<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/91363DD3-3DEA-4D93-93B7-7A44176DADCE"><gtr:id>91363DD3-3DEA-4D93-93B7-7A44176DADCE</gtr:id><gtr:name>Catholic University of Louvain</gtr:name><gtr:address><gtr:line1>3 Place L Pasteur</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/94FB5AD0-A6E5-4A49-8022-359A689D4259"><gtr:id>94FB5AD0-A6E5-4A49-8022-359A689D4259</gtr:id><gtr:name>Washington University in St Louis</gtr:name><gtr:address><gtr:line1>Washington University in St Louis</gtr:line1><gtr:line2>One Brookings Drive</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E682F0C-74B5-4907-891D-7BAC440B9540"><gtr:id>4E682F0C-74B5-4907-891D-7BAC440B9540</gtr:id><gtr:name>University of Georgia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/75450506-2C1F-43CF-9CC3-329FB463511B"><gtr:id>75450506-2C1F-43CF-9CC3-329FB463511B</gtr:id><gtr:name>Erasmus University Rotterdam (EUR)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Unknown</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/91363DD3-3DEA-4D93-93B7-7A44176DADCE"><gtr:id>91363DD3-3DEA-4D93-93B7-7A44176DADCE</gtr:id><gtr:name>Catholic University of Louvain</gtr:name><gtr:address><gtr:line1>3 Place L Pasteur</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/94FB5AD0-A6E5-4A49-8022-359A689D4259"><gtr:id>94FB5AD0-A6E5-4A49-8022-359A689D4259</gtr:id><gtr:name>Washington University in St Louis</gtr:name><gtr:address><gtr:line1>Washington University in St Louis</gtr:line1><gtr:line2>One Brookings Drive</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E682F0C-74B5-4907-891D-7BAC440B9540"><gtr:id>4E682F0C-74B5-4907-891D-7BAC440B9540</gtr:id><gtr:name>University of Georgia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/75450506-2C1F-43CF-9CC3-329FB463511B"><gtr:id>75450506-2C1F-43CF-9CC3-329FB463511B</gtr:id><gtr:name>Erasmus University Rotterdam (EUR)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6433BAE5-5750-4CAF-B009-AD2597263DB8"><gtr:id>6433BAE5-5750-4CAF-B009-AD2597263DB8</gtr:id><gtr:firstName>Rajesh</gtr:firstName><gtr:surname>Thakker</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9825289"><gtr:id>27F8473D-5539-4DA0-BF5F-71C2D861E1D6</gtr:id><gtr:title>Molecular Endocrinology of Parathyroid Disorders Affecting Calcium Homeostasis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9825289</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Parathyroid tumours, which affect 3:1,000 of the adult population, and congenital parathyroid developmental anomalies, which occur in 1:4,000 live births, are major causes of abnormal calcium and bone metabolism. We are investigating the molecular basis of such disorders by the combined use of the positional cloning and functional genomics approaches. Thus, in an integrated programme, we are studying the genetic control of parathyroid development, and the molecular events involved in parathyroid tumourigenesis. These two areas are complementary as tumourigenesis often results from the inappropriate expression of developmental genes. During 1999-2003, we showed that the hypoparathyroidism-deafness-renal dysplasia (HDR) syndrome is due to haploinsufficiency of the transcription factor GATA3; defined that a molecular deletional-insertion, involving chromosomes Xq27 and 2p25, causes X-linked hypoparathyroidism (XLHPT), which is due to parathyroid agenesis; and identified a novel gene causing hyperparathyroidism-jaw tumour (HPT-JT) syndrome. In addition, we have established a mouse knockout model for multiple endocrine neoplasia type 1 (MEN1); are generating chiameric mice that will help to establish a mouse knockout model for the HPT-JT syndrome; shown that GATA3 knockout mice represent an HDR phenotype; and that SOX3 knockout mice are likely to have abnormal parathyroid structure, which may contribute to the XLHPT phenotype. We now propose, in a continution of this programme, to elucidate the roles of the MEN1, HPT-JT, GATA3 and SOX3 genes in parathyroid functions and to use the MEN1 mouse model for investigating viral vectors in ex vivo and in vivo gene therapy studies. These studies will increase our understanding of the multi-step pathway in endocrine tumourigenesis and of the mechanisms regulating calcium homeostasis and parathyroid development. My group has made significant contributions to this field which is ideally placed at the basic science and clinical interface, and fits in with the MRC cancer priority area.</gtr:technicalSummary><gtr:fund><gtr:end>2011-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3115956</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Erasmus University Rotterdam</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Biomedical Genetics</gtr:department><gtr:description>Grosveld, F</gtr:description><gtr:id>947D0443-D4E5-4935-8944-F70EC5293E62</gtr:id><gtr:impact>20484821</gtr:impact><gtr:outcomeId>hNTbgnXQaW9-1</gtr:outcomeId><gtr:partnerContribution>Brought together different expertise and resources to answer a biological question.</gtr:partnerContribution><gtr:piContribution>Undertaken molecular genetic studies and mouse phenotyping analysis together with details for publication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Washington University in St Louis</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Dr M P Whyte, USA</gtr:description><gtr:id>792F0D5F-0656-4B3E-8CB6-2D932DF9942B</gtr:id><gtr:impact>19809483 16167084</gtr:impact><gtr:outcomeId>AC948183FAC-1</gtr:outcomeId><gtr:piContribution>Undertook molecular analysis and detailed scientific studies for the XLHPT project published in JCI 2005.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Harwell</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Mammalian Genetics Unit</gtr:department><gtr:description>Lyon MF</gtr:description><gtr:id>4E8F4A4B-EE5F-4722-8A91-6A7C6C96529A</gtr:id><gtr:impact>15347804</gtr:impact><gtr:outcomeId>4E932F215EB-1</gtr:outcomeId><gtr:piContribution>Identification of a CaSR mutation together with functional studies.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Clinical Medicine</gtr:department><gtr:description>Rorsman, P</gtr:description><gtr:id>F0E51661-FA90-4E64-9B86-BAE8F143D2AD</gtr:id><gtr:impact>209498720 19940036</gtr:impact><gtr:outcomeId>Ui9VKYiwc9E-1</gtr:outcomeId><gtr:partnerContribution>Brought together different expertise and resources to answer a biological question.</gtr:partnerContribution><gtr:piContribution>Undertaken molecular genetic studies and analysis together with details for publication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Georgia</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Genetics</gtr:department><gtr:description>Manley, N</gtr:description><gtr:id>D3A6E292-D116-4ACD-BA95-334DE356FAD2</gtr:id><gtr:impact>20484821</gtr:impact><gtr:outcomeId>nXCru7CToT6-1</gtr:outcomeId><gtr:partnerContribution>Brought together different expertise and resources to answer a biological question.</gtr:partnerContribution><gtr:piContribution>Undertaken molecular genetic studies and mouse phenotyping analysis together with details for publication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Mary Lyon Centre</gtr:department><gtr:description>Cox, R</gtr:description><gtr:id>9D5CE530-3CAB-4F25-BCD5-41102EB96AF6</gtr:id><gtr:impact>Several papers, full details under publications.</gtr:impact><gtr:outcomeId>mRNsk5K4gnZ-1</gtr:outcomeId><gtr:partnerContribution>Brought together different expertise and resources to answer a biological question.</gtr:partnerContribution><gtr:piContribution>Undertaken molecular genetic studies and mouse phenotyping analysis together with details for publication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Harwell</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Mammalian Genetics Unit</gtr:department><gtr:description>Cheeseman M</gtr:description><gtr:id>33C18F1D-AD5F-44DD-8FD1-2FF3B29BEE81</gtr:id><gtr:impact>19620250</gtr:impact><gtr:outcomeId>004119FB594-1</gtr:outcomeId><gtr:piContribution>Generated mouse model, undertook all studies except for histology.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Harwell</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Mammalian Genetics Unit</gtr:department><gtr:description>Brown, S</gtr:description><gtr:id>DB21ADB1-8E35-45C6-AD42-B13457CD17B8</gtr:id><gtr:impact>20457824</gtr:impact><gtr:outcomeId>GSMgUKwxpHb-1</gtr:outcomeId><gtr:partnerContribution>Brought together different expertise and resources to answer a biological question.</gtr:partnerContribution><gtr:piContribution>Undertaken molecular genetic studies and mouse phenotyping analysis together with details for publication.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Catholic University of Louvain</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:department>Department of Nephrology</gtr:department><gtr:description>Devuyst, Olivier</gtr:description><gtr:id>237DB4D0-11AA-4589-8611-7E4D1F4D1790</gtr:id><gtr:impact>20976470 20946626 19940036</gtr:impact><gtr:outcomeId>cXqCWaUZmWk-1</gtr:outcomeId><gtr:partnerContribution>Brought together different expertise and resources to answer a biological question.</gtr:partnerContribution><gtr:piContribution>Undertaken molecular genetic studies and analysis together with details for publication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit - Oxford High School, Oxford</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BE23662E-CE79-4B8E-8A31-32052FBC11B6</gtr:id><gtr:impact>40 students studying for A levels and GCSEs.

Generated interest in science and medicine with particular emphasis on genetics of cancer.</gtr:impact><gtr:outcomeId>3ABB2575B6F</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>AMEND Patient Support Group</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>514944E2-CCEB-4CA2-847A-DF43939F4E90</gtr:id><gtr:impact>Approximately 200 patients and their relatives attended the talk which raised important and interesting questions with discussions thereafter. The venue was at a hotel in Rugby (UK) over a weekend.

Raised interest amongst patients for the need for medical research.</gtr:impact><gtr:outcomeId>VHkjr4hkTPB</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient support group - AMEND</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7C385E30-4C5F-4E38-AEC3-F679CAA8B7BB</gtr:id><gtr:impact>Providing information for news letter.

Increases patient awareness.</gtr:impact><gtr:outcomeId>74EA9725DE6</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient support group - AMEND</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>743D405D-15CC-4E90-8C19-11FD920C6546</gtr:id><gtr:impact>Providing input at Annual Association meetings of AMEND. Advice on other issues in my capacity as Patron.

Increases pateint awareness.</gtr:impact><gtr:outcomeId>76F5C73FAB8</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New York Times</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B5E012E0-A956-4D61-A6A4-61480F3A7673</gtr:id><gtr:impact>Gave an interveiw to reporter (E Svoboda) from the New York Times about a paper that we had just published in Journal of Clincial Investigation (October 2005). New York Times article published on 7th February 2006 and entitled &amp;quot;Scientists sort through 'junk' to unravel a genetic mystery&amp;quot;.

Increased public awareness.</gtr:impact><gtr:outcomeId>7D338728F6E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Placement for undergraduate student</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>349C422C-FC3D-4043-86C6-C66C72749EDB</gtr:id><gtr:impact>Undergraduate student undertook a research project for one month and continued for the next year on a part time basis to complete this for final honors degree.

Degree obtained. Presentation of abstract at national British Endocrine Societies meeting.</gtr:impact><gtr:outcomeId>XRZxgyJshjW</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EuReGene European Renal Genome Project (10.2m euros across 14 participants)</gtr:description><gtr:end>2009-06-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>4A420AC9-03C2-4051-B0E0-8A264D7BEA91</gtr:id><gtr:outcomeId>F9E3115C8B50</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2005-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marie Curie Fellowship - E Kallay</gtr:description><gtr:end>2008-03-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>8F60BE84-48A0-4E03-989D-6B9A810E807C</gtr:id><gtr:outcomeId>75859106D420</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Training Fellowship (Newey)</gtr:description><gtr:end>2010-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F6B0775F-7EA2-440E-BD88-DC64C0FFCCB6</gtr:id><gtr:outcomeId>AA6C98B0E010</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Clinical Training Fellowship - M Javid</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>443AFA07-1198-4C00-9F7B-B9663C71AB29</gtr:id><gtr:outcomeId>ezsvcNDJtzP0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship - C Gorvin</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>FCF95801-D9D4-4C74-8B35-02871781BF54</gtr:id><gtr:outcomeId>cFEfAxPZ9Fv0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Collabortive Grant</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>43ABF60A-47AE-4039-9682-7A97F8E792E1</gtr:id><gtr:outcomeId>THyV18zWyUN</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Training Fellowship (Walls)</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>7FFFE69C-253C-4A29-9CC1-22EFD7E83953</gtr:id><gtr:outcomeId>02B22F32A9B0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Treat-OA</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>B6F022FE-6C50-41EB-8089-21ED881D307F</gtr:id><gtr:outcomeId>pGKyj1u8veV0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship - K Gaynor</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>4C3C453F-8FAD-481D-8FB8-77A66AE97086</gtr:id><gtr:outcomeId>pXUanb7RJip0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship - S Mirczuk</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B25C119B-2834-4A55-BAA1-0164514F8972</gtr:id><gtr:outcomeId>aagPe7ARhbK0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>032D8B79-5687-4497-8133-BDC17B6C7CE6</gtr:id><gtr:title>A novel MEN1 intronic mutation associated with multiple endocrine neoplasia type 1.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3718206226347df518c75fe2f24c131a"><gtr:id>3718206226347df518c75fe2f24c131a</gtr:id><gtr:otherNames>Lemos MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>B2856C0CFD7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BBCAD09-0B79-41E5-81FD-46462C5BAB06</gtr:id><gtr:title>Dent's disease.</gtr:title><gtr:parentPublicationTitle>Orphanet journal of rare diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/608251123dc45d3b69303af67aadc83f"><gtr:id>608251123dc45d3b69303af67aadc83f</gtr:id><gtr:otherNames>Devuyst O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1750-1172</gtr:issn><gtr:outcomeId>Ho7DybRo4vp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95BF6F53-CDFB-4A9E-B274-BF20C696FBC4</gtr:id><gtr:title>Familial isolated primary hyperparathyroidism caused by mutations of the MEN1 gene.</gtr:title><gtr:parentPublicationTitle>Nature clinical practice. Endocrinology &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb3e361f4680064c89a62f1e0816aa4"><gtr:id>2fb3e361f4680064c89a62f1e0816aa4</gtr:id><gtr:otherNames>Hannan FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1745-8366</gtr:issn><gtr:outcomeId>518C6FD3D75</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B39B5E1-92D0-4C63-BC33-34765A1DE1E3</gtr:id><gtr:title>Hypophosphatemic rickets is associated with disruption of mineral orientation at the nanoscale in the flat scapula bones of rachitic mice with development.</gtr:title><gtr:parentPublicationTitle>Bone</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/485fae73aaa56c4f03380b50f6866902"><gtr:id>485fae73aaa56c4f03380b50f6866902</gtr:id><gtr:otherNames>Karunaratne A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1873-2763</gtr:issn><gtr:outcomeId>pm_14810_20_22609228</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3876E371-6182-4A4C-8B2C-C14AEA0819AA</gtr:id><gtr:title>Significant deterioration in nanomechanical quality occurs through incomplete extrafibrillar mineralization in rachitic bone: evidence from in-situ synchrotron X-ray scattering and backscattered electron imaging.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/485fae73aaa56c4f03380b50f6866902"><gtr:id>485fae73aaa56c4f03380b50f6866902</gtr:id><gtr:otherNames>Karunaratne A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>pm_14810_20_22161748</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE23CEE6-BD33-443B-8BB5-55E62BFD1DEE</gtr:id><gtr:title>Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b52b61d3e3709d22522d044d591de5c9"><gtr:id>b52b61d3e3709d22522d044d591de5c9</gtr:id><gtr:otherNames>Thakker RV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>pm_14810_20_22723327</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51F2C2F5-6FA3-4899-80E4-2B465FBF7415</gtr:id><gtr:title>Establishing normal plasma and 24-hour urinary biochemistry ranges in C3H, BALB/c and C57BL/6J mice following acclimatization in metabolic cages.</gtr:title><gtr:parentPublicationTitle>Laboratory animals</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ffdf89415bf00d701ee8134ddbdd49e"><gtr:id>1ffdf89415bf00d701ee8134ddbdd49e</gtr:id><gtr:otherNames>Stechman MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0023-6772</gtr:issn><gtr:outcomeId>ZskDekDPQdT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E71DB56D-C597-4F8F-9033-237A41B04EA7</gtr:id><gtr:title>Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a0481551021c409f7506d2f06ea4564"><gtr:id>9a0481551021c409f7506d2f06ea4564</gtr:id><gtr:otherNames>Duncan EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>fSeBsApcQmP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89B69F93-68E2-4006-9F4B-DACC2771BBDE</gtr:id><gtr:title>Symmetrically reduced stiffness and increased extensibility in compression and tension at the mineralized fibrillar level in rachitic bone.</gtr:title><gtr:parentPublicationTitle>Bone</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/485fae73aaa56c4f03380b50f6866902"><gtr:id>485fae73aaa56c4f03380b50f6866902</gtr:id><gtr:otherNames>Karunaratne A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1873-2763</gtr:issn><gtr:outcomeId>pm_14810_20_23128355</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3590C4CE-FC85-4288-85AE-0FC7A68E42BD</gtr:id><gtr:title>Autosomal dominant hypercalciuria in a mouse model due to a mutation of the epithelial calcium channel, TRPV5.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4afd07a38cd306c5f99be9de1030ef21"><gtr:id>4afd07a38cd306c5f99be9de1030ef21</gtr:id><gtr:otherNames>Loh NY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14810_20_23383183</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C950AD7-FEF0-4F2C-8666-8BA4A66A42F3</gtr:id><gtr:title>MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08a67913704857049cd961e429f8dd62"><gtr:id>08a67913704857049cd961e429f8dd62</gtr:id><gtr:otherNames>Walls GV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>pm_14810_20_22915754</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2750FFAF-DB13-454A-B895-4CC7B0CA67FB</gtr:id><gtr:title>Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08a67913704857049cd961e429f8dd62"><gtr:id>08a67913704857049cd961e429f8dd62</gtr:id><gtr:otherNames>Walls GV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>5a31df7154c291.37967194</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5EF5AF8-D91C-4327-AD95-861881A3B111</gtr:id><gtr:title>Phase II study of single agent capecitabine in the treatment of metastatic non-pancreatic neuroendocrine tumours.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81b3b301eda9bae75b5845db1e012d7a"><gtr:id>81b3b301eda9bae75b5845db1e012d7a</gtr:id><gtr:otherNames>Medley L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>eqqPnYrBBRX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42CDF989-C690-4100-8DE2-EC896E7BD6BD</gtr:id><gtr:title>Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d744b37eab5d54815ab8dca6c36aae5"><gtr:id>5d744b37eab5d54815ab8dca6c36aae5</gtr:id><gtr:otherNames>Wang P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>714C5C1A53F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F56977B-C7B3-4F66-B643-F8AC2E25E723</gtr:id><gtr:title>Gastroenteropancreatic neuroendocrine tumours.</gtr:title><gtr:parentPublicationTitle>The Lancet. Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69a830cea4a7300ede6bc05292f75b47"><gtr:id>69a830cea4a7300ede6bc05292f75b47</gtr:id><gtr:otherNames>Modlin IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1470-2045</gtr:issn><gtr:outcomeId>6F213841092</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>181CF93A-48EE-47F4-AFB4-9532DBC7E7A0</gtr:id><gtr:title>Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype-phenotype correlations, codon bias and dominant-negative effects.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb3e361f4680064c89a62f1e0816aa4"><gtr:id>2fb3e361f4680064c89a62f1e0816aa4</gtr:id><gtr:otherNames>Hannan FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5675e6b4aac69</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF8853BF-8BDE-42F0-8430-10AC1CEE9D15</gtr:id><gtr:title>Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis.</gtr:title><gtr:parentPublicationTitle>Journal of molecular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb3e361f4680064c89a62f1e0816aa4"><gtr:id>2fb3e361f4680064c89a62f1e0816aa4</gtr:id><gtr:otherNames>Hannan FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0952-5041</gtr:issn><gtr:outcomeId>5a6db016076f56.08285028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E4DA56A-DD9D-4440-851D-994A3303CABA</gtr:id><gtr:title>The Calcilytic Agent NPS 2143 Rectifies Hypocalcemia in a Mouse Model With an Activating Calcium-Sensing Receptor (CaSR) Mutation: Relevance to Autosomal Dominant Hypocalcemia Type 1 (ADH1).</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb3e361f4680064c89a62f1e0816aa4"><gtr:id>2fb3e361f4680064c89a62f1e0816aa4</gtr:id><gtr:otherNames>Hannan FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>5675e60d2aecb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74E2B2B4-0831-4CB9-A990-D7CA3F497A1E</gtr:id><gtr:title>Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b08bc1da63361198efc47ffc07daa23c"><gtr:id>b08bc1da63361198efc47ffc07daa23c</gtr:id><gtr:otherNames>Grigorieva IV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>qbLY1HQ4UGm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDCC549A-0231-457E-9963-9516F9F28663</gtr:id><gtr:title>Role of multiple endocrine neoplasia type 1 mutational analysis in clinical practice.</gtr:title><gtr:parentPublicationTitle>Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4012bab03e044a389467d6bd29325d39"><gtr:id>4012bab03e044a389467d6bd29325d39</gtr:id><gtr:otherNames>Newey PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1530-891X</gtr:issn><gtr:outcomeId>nHCRzanQHWS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7B7F3F3-960B-48DE-92BC-8A92165782A1</gtr:id><gtr:title>Genome-wide study of familial juvenile hyperuricaemic (gouty) nephropathy (FJHN) indicates a new locus, FJHN3, linked to chromosome 2p22.1-p21.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d1ac2130962ee63f2defcb9b59a8461"><gtr:id>9d1ac2130962ee63f2defcb9b59a8461</gtr:id><gtr:otherNames>Piret SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn><gtr:outcomeId>rb2e4KVRuUz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4200B66-00AF-4C8F-8B0D-2824948CB12C</gtr:id><gtr:title>Mutant prolactin receptor and familial hyperprolactinemia.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4012bab03e044a389467d6bd29325d39"><gtr:id>4012bab03e044a389467d6bd29325d39</gtr:id><gtr:otherNames>Newey PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_14810_20_24195502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28C09A77-CBAE-43A3-B31B-B2FED53AF436</gtr:id><gtr:title>Mouse models for inherited endocrine and metabolic disorders.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d1ac2130962ee63f2defcb9b59a8461"><gtr:id>9d1ac2130962ee63f2defcb9b59a8461</gtr:id><gtr:otherNames>Piret SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>rE92ZDirium</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06544192-E000-4F7A-984E-0B269320758C</gtr:id><gtr:title>Comparison of human chromosome 19q13 and syntenic region on mouse chromosome 7 reveals absence, in man, of 11.6 Mb containing four mouse calcium-sensing receptor-related sequences: relevance to familial benign hypocalciuric hypercalcaemia type 3.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb3e361f4680064c89a62f1e0816aa4"><gtr:id>2fb3e361f4680064c89a62f1e0816aa4</gtr:id><gtr:otherNames>Hannan FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>jEP1DoSDxa8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>705A81BC-11E1-407D-8C1C-F054D56A1FA0</gtr:id><gtr:title>Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d10a0ee7ef278dd7fec416e497281585"><gtr:id>d10a0ee7ef278dd7fec416e497281585</gtr:id><gtr:otherNames>Yu W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>doi_55faa2aa221df03c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE2327BC-B1FB-49B2-9B7D-F3E97E4BAC7C</gtr:id><gtr:title>Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism.</gtr:title><gtr:parentPublicationTitle>Best practice &amp; research. Clinical endocrinology &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb3e361f4680064c89a62f1e0816aa4"><gtr:id>2fb3e361f4680064c89a62f1e0816aa4</gtr:id><gtr:otherNames>Hannan FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1521-690X</gtr:issn><gtr:outcomeId>doi_55faa2aa220a6dee</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6034D27A-DD41-4EB3-AB34-114FA22C6282</gtr:id><gtr:title>Expression profiling of colorectal cancer cells reveals inhibition of DNA replication licensing by extracellular calcium.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/286ad8dd6acb6dc065094f60ddb9d0d5"><gtr:id>286ad8dd6acb6dc065094f60ddb9d0d5</gtr:id><gtr:otherNames>Aggarwal A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>5a2fd5c7379676.52113771</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D30B67D3-D736-4E01-880F-2D6E2EDBD318</gtr:id><gtr:title>CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a1dae580c251b82000f5e5d0fa5eefa"><gtr:id>8a1dae580c251b82000f5e5d0fa5eefa</gtr:id><gtr:otherNames>Korpi-Hy?v?lti E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>5461d35ecbb680.18907414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08A679CC-6A97-423E-A024-269D2DCF67BF</gtr:id><gtr:title>A mouse model for spondyloepiphyseal dysplasia congenita with secondary osteoarthritis due to a Col2a1 mutation.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe10ebdb8ef07071e879e1ba8081ed4"><gtr:id>0fe10ebdb8ef07071e879e1ba8081ed4</gtr:id><gtr:otherNames>Esapa CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>pm_14810_20_22028304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6D794AA-DF75-4D43-8DAA-1F3B1FA8F25A</gtr:id><gtr:title>Animal models of pituitary neoplasia.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f4cc013f35def12bb324155e5e926b6"><gtr:id>9f4cc013f35def12bb324155e5e926b6</gtr:id><gtr:otherNames>Lines KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>585d5792c5de32.75550575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A74D0CB2-A525-47CC-93E2-985A2A9547FD</gtr:id><gtr:title>Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0595a7d8bf7c30b67c83c71fcc8d9e98"><gtr:id>0595a7d8bf7c30b67c83c71fcc8d9e98</gtr:id><gtr:otherNames>Taylor JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5675e4a74fa86</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2763C0F9-1A6E-4105-AFEC-77DC19B2656D</gtr:id><gtr:title>Genetics of hypercalciuric nephrolithiasis: renal stone disease.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ffdf89415bf00d701ee8134ddbdd49e"><gtr:id>1ffdf89415bf00d701ee8134ddbdd49e</gtr:id><gtr:otherNames>Stechman MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>CCB5A15892A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC050755-8603-4858-BB49-7FE987CD1F24</gtr:id><gtr:title>Parafibromin--functional insights.</gtr:title><gtr:parentPublicationTitle>Journal of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4012bab03e044a389467d6bd29325d39"><gtr:id>4012bab03e044a389467d6bd29325d39</gtr:id><gtr:otherNames>Newey PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0954-6820</gtr:issn><gtr:outcomeId>1A1AE49E646</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41202093-7295-458A-A77E-083C78E87E7B</gtr:id><gtr:title>Hypercalcemic Disorders in Children.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d264df2dd07f121ecec3e171984a00da"><gtr:id>d264df2dd07f121ecec3e171984a00da</gtr:id><gtr:otherNames>Stokes VJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>5a2fda585306e2.01787436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C96A7842-F64A-41A4-86FF-C9248FE595A8</gtr:id><gtr:title>Proliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08a67913704857049cd961e429f8dd62"><gtr:id>08a67913704857049cd961e429f8dd62</gtr:id><gtr:otherNames>Walls GV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>pm_14810_20_23024266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>242AF72D-15EC-4749-829F-49EAA2FB3489</gtr:id><gtr:title>Characteristics of hearing loss in HDR (hypoparathyroidism, sensorineural deafness, renal dysplasia) syndrome.</gtr:title><gtr:parentPublicationTitle>Audiology &amp; neuro-otology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05cc735bf053caf51539a05021a78b70"><gtr:id>05cc735bf053caf51539a05021a78b70</gtr:id><gtr:otherNames>van Looij MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1420-3030</gtr:issn><gtr:outcomeId>5451D4265BC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C69B592F-291C-440A-9DFD-FFFEA2CBCDD6</gtr:id><gtr:title>Transcription factors in parathyroid development: lessons from hypoparathyroid disorders.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b08bc1da63361198efc47ffc07daa23c"><gtr:id>b08bc1da63361198efc47ffc07daa23c</gtr:id><gtr:otherNames>Grigorieva IV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>CyXzfEbJqdN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBEFB3B7-9B18-4099-BE0F-CD6840DE0362</gtr:id><gtr:title>A mouse with an N-Ethyl-N-nitrosourea (ENU) Induced Trp589Arg Galnt3 mutation represents a model for hyperphosphataemic familial tumoural calcinosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe10ebdb8ef07071e879e1ba8081ed4"><gtr:id>0fe10ebdb8ef07071e879e1ba8081ed4</gtr:id><gtr:otherNames>Esapa CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14810_20_22912827</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>719DE603-F2BA-481B-8359-98A364AAEDA7</gtr:id><gtr:title>Multiple endocrine neoplasia type 1 (MEN1).</gtr:title><gtr:parentPublicationTitle>Best practice &amp; research. Clinical endocrinology &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b52b61d3e3709d22522d044d591de5c9"><gtr:id>b52b61d3e3709d22522d044d591de5c9</gtr:id><gtr:otherNames>Thakker RV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1521-690X</gtr:issn><gtr:outcomeId>nYjrCv9GTRg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A881DA3-A27F-4D0B-BA8A-A90F88D300AD</gtr:id><gtr:title>CLC-5 and KIF3B interact to facilitate CLC-5 plasma membrane expression, endocytosis, and microtubular transport: relevance to pathophysiology of Dent's disease.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Renal physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcf920024b0056f69b2e20578fef2729"><gtr:id>dcf920024b0056f69b2e20578fef2729</gtr:id><gtr:otherNames>Reed AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1522-1466</gtr:issn><gtr:outcomeId>rV1eZh8e7G3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7256AB85-CC3A-4729-882D-171930347E0D</gtr:id><gtr:title>Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein a-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d58083c75b1d9f7c09d81ffcaaabb06"><gtr:id>4d58083c75b1d9f7c09d81ffcaaabb06</gtr:id><gtr:otherNames>Babinsky VN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>585d37303aab48.69857012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4228515-A733-4C87-83BA-6B680041AE49</gtr:id><gtr:title>Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1-Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08a67913704857049cd961e429f8dd62"><gtr:id>08a67913704857049cd961e429f8dd62</gtr:id><gtr:otherNames>Walls GV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>585d69319ea471.31714418</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>579FD3EC-0BAD-4099-B139-4EF93233DD9C</gtr:id><gtr:title>Membrane targeting and secretion of mutant uromodulin in familial juvenile hyperuricemic nephropathy.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7249e92d84f50b11e1f55f0b5445563d"><gtr:id>7249e92d84f50b11e1f55f0b5445563d</gtr:id><gtr:otherNames>Jennings P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>291980A0C36</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27D98BEA-8677-4A43-B73F-3A3520B65B43</gtr:id><gtr:title>An N-ethyl-N-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excess.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff9ff780a2c6c6c409cf9d75f12ebab5"><gtr:id>ff9ff780a2c6c6c409cf9d75f12ebab5</gtr:id><gtr:otherNames>Bentley L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>doi_55f9859856942fe6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2026CC2-C7CD-4ED6-A8BA-FD666ADE11B4</gtr:id><gtr:title>&lt;i>OCRL1&lt;/i> Mutations in Dent 2 Patients Suggest a Mechanism for Phenotypic Variability</gtr:title><gtr:parentPublicationTitle>Nephron Physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f70daf98f66755b6b5ce060e39c14cd8"><gtr:id>f70daf98f66755b6b5ce060e39c14cd8</gtr:id><gtr:otherNames>Shrimpton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1660-2137</gtr:issn><gtr:outcomeId>7F8AAC38B3E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60AC543A-CACF-499A-A313-A0080F6AC4B6</gtr:id><gtr:title>Cinacalcet for Symptomatic Hypercalcemia Caused by AP2S1 Mutations.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57ed3785894d2593d33f95af70ae8b5b"><gtr:id>57ed3785894d2593d33f95af70ae8b5b</gtr:id><gtr:otherNames>Howles SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>58c6aec2688da7.92457287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A3CC894-1986-4E73-9BFC-5015FCF8C692</gtr:id><gtr:title>Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4012bab03e044a389467d6bd29325d39"><gtr:id>4012bab03e044a389467d6bd29325d39</gtr:id><gtr:otherNames>Newey PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>FB1C028A795</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBE20AE9-6EC3-4B78-A8BD-88CB5FF5B567</gtr:id><gtr:title>Mutational analysis of CLC-5, cofilin and CLC-4 in patients with Dent's disease.</gtr:title><gtr:parentPublicationTitle>Nephron. Physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d78563168f7d24f89cb327fe1ba977f"><gtr:id>1d78563168f7d24f89cb327fe1ba977f</gtr:id><gtr:otherNames>Wu F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1660-2137</gtr:issn><gtr:outcomeId>79CCACE1207</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B64AE4A4-8930-4D6E-8E06-5DE62980BB16</gtr:id><gtr:title>Genetic background influences embryonic lethality and the occurrence of neural tube defects in Men1 null mice: relevance to genetic modifiers.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3718206226347df518c75fe2f24c131a"><gtr:id>3718206226347df518c75fe2f24c131a</gtr:id><gtr:otherNames>Lemos MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>5D2D5FADE37</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BEF1418-13A9-4999-AA72-2FBDD6AE7E3B</gtr:id><gtr:title>Characterization of Dent's disease mutations of CLC-5 reveals a correlation between functional and cell biological consequences and protein structure.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Renal physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5f45f6d8e8d1f272f378d4ec22d09f0"><gtr:id>c5f45f6d8e8d1f272f378d4ec22d09f0</gtr:id><gtr:otherNames>Smith AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1522-1466</gtr:issn><gtr:outcomeId>E79E99C6A63</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCDF62DB-A6B1-4C7E-B8BF-230CA1ED0E7B</gtr:id><gtr:title>Anatomic and functional imaging of metastatic carcinoid tumors.</gtr:title><gtr:parentPublicationTitle>Radiographics : a review publication of the Radiological Society of North America, Inc</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1b1efaf76b14ad7e79da0d130ea2b1f"><gtr:id>e1b1efaf76b14ad7e79da0d130ea2b1f</gtr:id><gtr:otherNames>Scarsbrook AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0271-5333</gtr:issn><gtr:outcomeId>BDC07DF2CC5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B823C14-9538-4617-A101-4EA0AF7636AD</gtr:id><gtr:title>Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b27196135747e78e764e0681cfdce79"><gtr:id>9b27196135747e78e764e0681cfdce79</gtr:id><gtr:otherNames>Bradley KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>FB87A9E6CC8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4ABDA590-3119-40DE-972A-655B473EFDE0</gtr:id><gtr:title>Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1).</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7174c61d83c3ff6274bb831026dce87e"><gtr:id>7174c61d83c3ff6274bb831026dce87e</gtr:id><gtr:otherNames>Turner JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>E9MQCEX4ERC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>331F11A2-4587-4E7A-A57B-5A19153185DB</gtr:id><gtr:title>Genetics of parathyroid tumours.</gtr:title><gtr:parentPublicationTitle>Journal of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b52b61d3e3709d22522d044d591de5c9"><gtr:id>b52b61d3e3709d22522d044d591de5c9</gtr:id><gtr:otherNames>Thakker RV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0954-6820</gtr:issn><gtr:outcomeId>585d3a1b01b1b7.82092161</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E309E54D-7479-481E-92F6-DC873640C94E</gtr:id><gtr:title>Uromodulin mutations causing familial juvenile hyperuricaemic nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0568edb4cfe216fbbbfa2f06290301de"><gtr:id>0568edb4cfe216fbbbfa2f06290301de</gtr:id><gtr:otherNames>Williams SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>9263D2F2758</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11DF0E1F-C47C-49CA-AA68-AFED9FE5A8B1</gtr:id><gtr:title>Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb3e361f4680064c89a62f1e0816aa4"><gtr:id>2fb3e361f4680064c89a62f1e0816aa4</gtr:id><gtr:otherNames>Hannan FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>CEB87DA0B54</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>195F769D-70F8-4B8A-BAF4-4A8FE918D4E3</gtr:id><gtr:title>Functional characterization of calcium sensing receptor polymorphisms and absence of association with indices of calcium homeostasis and bone mineral density.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70b86cba6ffbb0385b12ed04c952995c"><gtr:id>70b86cba6ffbb0385b12ed04c952995c</gtr:id><gtr:otherNames>Harding B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>F19E27099CA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D90C4364-1B03-4C08-A5B3-204AF4BA2715</gtr:id><gtr:title>Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3718206226347df518c75fe2f24c131a"><gtr:id>3718206226347df518c75fe2f24c131a</gtr:id><gtr:otherNames>Lemos MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>37B673E6114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00C8C092-27E0-4835-8D48-65942AA9315C</gtr:id><gtr:title>Identification and characterization of novel parathyroid-specific transcription factor Glial Cells Missing Homolog B (GCMB) mutations in eight families with autosomal recessive hypoparathyroidism.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43894d355de9d04f1cd617d762806618"><gtr:id>43894d355de9d04f1cd617d762806618</gtr:id><gtr:otherNames>Bowl MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>ewFfwdtnXK1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44DBEAEC-9DE5-4495-9B9F-96B2A9F6F2B5</gtr:id><gtr:title>Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4012bab03e044a389467d6bd29325d39"><gtr:id>4012bab03e044a389467d6bd29325d39</gtr:id><gtr:otherNames>Newey PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>aenngcwXdsp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FA6BAA7-60B1-4FCE-AAAF-08F6F42827BC</gtr:id><gtr:title>GATA3 mutations found in breast cancers may be associated with aberrant nuclear localization, reduced transactivation and cell invasiveness.</gtr:title><gtr:parentPublicationTitle>Hormones &amp; cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93e808505e64ab355d2468c6eae119ec"><gtr:id>93e808505e64ab355d2468c6eae119ec</gtr:id><gtr:otherNames>Gaynor KU</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1868-8497</gtr:issn><gtr:outcomeId>pm_14810_20_23435732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BFDD4D0-14B2-466F-A86A-3367AE0F9BC5</gtr:id><gtr:title>SEDLIN forms homodimers: characterisation of SEDLIN mutations and their interactions with transcription factors MBP1, PITX1 and SF1.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95743ea57af3393f310f6a89fd105330"><gtr:id>95743ea57af3393f310f6a89fd105330</gtr:id><gtr:otherNames>Jeyabalan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>SPHWo7PgdZ2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41E700FF-2DBF-4C30-89B0-D4C6F1C4B70D</gtr:id><gtr:title>A mouse model of early-onset renal failure due to a xanthine dehydrogenase nonsense mutation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d1ac2130962ee63f2defcb9b59a8461"><gtr:id>9d1ac2130962ee63f2defcb9b59a8461</gtr:id><gtr:otherNames>Piret SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14810_20_23024809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1438A9D5-8966-4522-B71D-E4F78E3A427C</gtr:id><gtr:title>A missense glial cells missing homolog B (GCMB) mutation, Asn502His, causes autosomal dominant hypoparathyroidism.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45b25390b627d7dd045dcc86d70bd8c5"><gtr:id>45b25390b627d7dd045dcc86d70bd8c5</gtr:id><gtr:otherNames>Mirczuk SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>hfwQbmSt6Zn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0FA1267-0ABA-46BC-9B06-EAD71C5223F2</gtr:id><gtr:title>N-ethyl-N-Nitrosourea (ENU) induced mutations within the klotho gene lead to ectopic calcification and reduced lifespan in mouse models.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe10ebdb8ef07071e879e1ba8081ed4"><gtr:id>0fe10ebdb8ef07071e879e1ba8081ed4</gtr:id><gtr:otherNames>Esapa CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_55f985985ddd6fb4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40D66326-AE77-4B6F-A8BD-279148830E91</gtr:id><gtr:title>Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f588712875eb3f2079940bef7af8448"><gtr:id>6f588712875eb3f2079940bef7af8448</gtr:id><gtr:otherNames>Nesbit MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_14810_20_23222959</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D70113E3-3498-4CF6-B114-9A1C0B226AC1</gtr:id><gtr:title>Multiple endocrine neoplasia: spectrum of radiologic appearances and discussion of a multitechnique imaging approach.</gtr:title><gtr:parentPublicationTitle>Radiographics : a review publication of the Radiological Society of North America, Inc</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1b1efaf76b14ad7e79da0d130ea2b1f"><gtr:id>e1b1efaf76b14ad7e79da0d130ea2b1f</gtr:id><gtr:otherNames>Scarsbrook AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0271-5333</gtr:issn><gtr:outcomeId>C9A5D8B34DB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F445A1B2-E281-4091-A393-3EDFD8E57864</gtr:id><gtr:title>HDR syndrome: a follow-up genotype-phenotype analysis of a de novo missense Thr272Ile mutation in exon 4 of GATA3.</gtr:title><gtr:parentPublicationTitle>Klinische Padiatrie</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4a712c1ab30617423392b7414b5356f"><gtr:id>f4a712c1ab30617423392b7414b5356f</gtr:id><gtr:otherNames>Gomes TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0300-8630</gtr:issn><gtr:outcomeId>pm_14810_20_23203342</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C65BC875-8611-4643-8862-821BF3596D51</gtr:id><gtr:title>Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f392e2e926f042fbe3cfa981e4fed71"><gtr:id>6f392e2e926f042fbe3cfa981e4fed71</gtr:id><gtr:otherNames>Ali A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>AD21AD8FA60</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F61A827-FBB2-4D29-B1A3-07CAB5701E5A</gtr:id><gtr:title>Mutations affecting G-protein subunit a11 in hypercalcemia and hypocalcemia.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f588712875eb3f2079940bef7af8448"><gtr:id>6f588712875eb3f2079940bef7af8448</gtr:id><gtr:otherNames>Nesbit MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>5461d35f25de01.12701910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6325C30A-9822-409B-A06A-31376C0E6EFC</gtr:id><gtr:title>Receptor-mediated endocytosis and endosomal acidification is impaired in proximal tubule epithelial cells of Dent disease patients.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be3d7fbaa94ddd1c4d54cd8939adddda"><gtr:id>be3d7fbaa94ddd1c4d54cd8939adddda</gtr:id><gtr:otherNames>Gorvin CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5461d35f7c0145.83944392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89F71C8F-9BC2-4AC7-841E-7D32B723F42B</gtr:id><gtr:title>A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb3e361f4680064c89a62f1e0816aa4"><gtr:id>2fb3e361f4680064c89a62f1e0816aa4</gtr:id><gtr:otherNames>Hannan FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>jXxagJSwQrA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F21CCF34-52A4-49A4-BD95-61B8423475E6</gtr:id><gtr:title>Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia.</gtr:title><gtr:parentPublicationTitle>Endocrine-related cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70b86cba6ffbb0385b12ed04c952995c"><gtr:id>70b86cba6ffbb0385b12ed04c952995c</gtr:id><gtr:otherNames>Harding B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1351-0088</gtr:issn><gtr:outcomeId>34C0FD424B3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39580BE7-0E7A-47DF-B8DD-3914F1D38E4D</gtr:id><gtr:title>Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a78bec2ee706e6291c4debe42b6b64fa"><gtr:id>a78bec2ee706e6291c4debe42b6b64fa</gtr:id><gtr:otherNames>Cardoso L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>5a2fd697851e42.03249231</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA532E61-E4C9-48F9-A646-F0827BEACC31</gtr:id><gtr:title>Identification of a second kindred with familial hypocalciuric hypercalcemia type 3 (FHH3) narrows localization to a &amp;lt;3.5 megabase pair region on chromosome 19q13.3.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f588712875eb3f2079940bef7af8448"><gtr:id>6f588712875eb3f2079940bef7af8448</gtr:id><gtr:otherNames>Nesbit MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>sncwDqULXcj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8BD56ED-CAA4-4F4F-9268-DCA63D77BCFC</gtr:id><gtr:title>Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4012bab03e044a389467d6bd29325d39"><gtr:id>4012bab03e044a389467d6bd29325d39</gtr:id><gtr:otherNames>Newey PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>pm_14810_20_22855342</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E87B4122-5089-46D1-BC37-6975996EDB6B</gtr:id><gtr:title>Genetic causes of hypercalciuric nephrolithiasis.</gtr:title><gtr:parentPublicationTitle>Pediatric nephrology (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ffdf89415bf00d701ee8134ddbdd49e"><gtr:id>1ffdf89415bf00d701ee8134ddbdd49e</gtr:id><gtr:otherNames>Stechman MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0931-041X</gtr:issn><gtr:outcomeId>654EA88BF9E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>598007B8-D6DD-4E46-8374-B355A4923107</gtr:id><gtr:title>Pseudohypoparathyroidism type 1a due to a novel mutation in the GNAS gene.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3718206226347df518c75fe2f24c131a"><gtr:id>3718206226347df518c75fe2f24c131a</gtr:id><gtr:otherNames>Lemos MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>585d5728974773.66301253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1829E0E-C65D-49CC-BEC9-947E6340DD67</gtr:id><gtr:title>Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb3e361f4680064c89a62f1e0816aa4"><gtr:id>2fb3e361f4680064c89a62f1e0816aa4</gtr:id><gtr:otherNames>Hannan FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_14810_20_22422767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36E31752-5FCC-4782-8150-5017B98803FE</gtr:id><gtr:title>Mutational analysis of the adaptor protein 2 sigma subunit (AP2S1) gene: search for autosomal dominant hypocalcemia type 3 (ADH3).</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b64fe6ed8f54145940378d4d138c74f5"><gtr:id>b64fe6ed8f54145940378d4d138c74f5</gtr:id><gtr:otherNames>Rogers A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>pm_540e17ee17eb5bfb9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C9AA2BD-8094-4A9B-A24C-34FBE14E6878</gtr:id><gtr:title>A missense GATA3 mutation, Thr272Ile, causes the hypoparathyroidism, deafness, and renal dysplasia syndrome.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93e808505e64ab355d2468c6eae119ec"><gtr:id>93e808505e64ab355d2468c6eae119ec</gtr:id><gtr:otherNames>Gaynor KU</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>2229C82C998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41203B33-97EF-4989-A3EE-3C0076231FC1</gtr:id><gtr:title>Parafibromin is a nuclear protein with a functional monopartite nuclear localization signal.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b27196135747e78e764e0681cfdce79"><gtr:id>9b27196135747e78e764e0681cfdce79</gtr:id><gtr:otherNames>Bradley KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>D1D3E6518FA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14125628-8B62-41DE-918C-5529AE83BD66</gtr:id><gtr:title>Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c04409703a15a781751ba68128436aad"><gtr:id>c04409703a15a781751ba68128436aad</gtr:id><gtr:otherNames>Ramage JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>CnkETJ2c7hy</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9825289</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>